Select Medical Holdings Gestion
Gestion contrôle des critères 1/4
Le PDG Select Medical Holdings est David Chernow, nommé en Jan2014, a un mandat de 10.83 ans. La rémunération annuelle totale est $ 10.71M, composée du salaire de 9.3% et des bonus 90.7%, y compris les actions et options de la société. détient directement 0.73% des actions de la société, d'une valeur de $ 35.79M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.1 ans et 14.5 ans.
Informations clés
David Chernow
Directeur général
US$10.7m
Rémunération totale
| Pourcentage du salaire du PDG | 9.3% |
| Durée du mandat du directeur général | 10.8yrs |
| Propriété du PDG | 0.7% |
| Durée moyenne d'occupation des postes de direction | 1.1yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 14.5yrs |
Mises à jour récentes de la gestion
Recent updates
Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125
Nov 04
Returns Are Gaining Momentum At Select Medical Holdings (NYSE:SEM)
Oct 21Select Medical Holdings: No Reason To Downgrade This One Just Yet
Oct 07Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?
Oct 03Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125
Aug 05Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher
Jul 19What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?
Jul 01Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?
Jun 13There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price
May 26Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
May 05Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely
Apr 19Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down
Apr 11Select Medical: Solid Growth Prospects And A Compelling Valuation
Mar 05Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely
Feb 18We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt
Jan 15Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes
Dec 31Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125
Nov 06Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors
Oct 25What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?
Oct 04Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?
Sep 16Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold
Aug 11Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125
Aug 07Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward
Jul 14At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?
Jun 29Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden
May 27Select Medical: Revising To Hold As Business Economics Roll Lower
May 26Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital
Apr 05Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?
Mar 17Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line
Feb 23Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden
Jan 31The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence
Dec 20Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?
Dec 01Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$266m |
| Jun 30 2024 | n/a | n/a | US$259m |
| Mar 31 2024 | n/a | n/a | US$260m |
| Dec 31 2023 | US$11m | US$995k | US$235m |
| Sep 30 2023 | n/a | n/a | US$217m |
| Jun 30 2023 | n/a | n/a | US$196m |
| Mar 31 2023 | n/a | n/a | US$174m |
| Dec 31 2022 | US$9m | US$995k | US$153m |
| Sep 30 2022 | n/a | n/a | US$175m |
| Jun 30 2022 | n/a | n/a | US$223m |
| Mar 31 2022 | n/a | n/a | US$329m |
| Dec 31 2021 | US$12m | US$995k | US$389m |
| Sep 30 2021 | n/a | n/a | US$415m |
| Jun 30 2021 | n/a | n/a | US$415m |
| Mar 31 2021 | n/a | n/a | US$306m |
| Dec 31 2020 | US$8m | US$995k | US$250m |
| Sep 30 2020 | n/a | n/a | US$206m |
| Jun 30 2020 | n/a | n/a | US$162m |
| Mar 31 2020 | n/a | n/a | US$155m |
| Dec 31 2019 | US$8m | US$995k | US$143m |
| Sep 30 2019 | n/a | n/a | US$136m |
| Jun 30 2019 | n/a | n/a | US$138m |
| Mar 31 2019 | n/a | n/a | US$140m |
| Dec 31 2018 | US$8m | US$995k | US$133m |
| Sep 30 2018 | n/a | n/a | US$207m |
| Jun 30 2018 | n/a | n/a | US$193m |
| Mar 31 2018 | n/a | n/a | US$189m |
| Dec 31 2017 | US$7m | US$984k | US$171m |
Rémunération vs marché: La rémunération totale de David ($USD 10.71M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 7.94M ).
Rémunération et revenus: La rémunération de David a augmenté de plus de 20 % au cours de l'année écoulée.
PDG
David Chernow (67 yo)
10.8yrs
Titularisation
US$10,706,265
Compensation
Mr. David S. Chernow serves as Director at Exokinetics, Inc. He has been the Chief Executive Officer at Select Medical Holdings Corporation and Select Medical Corporation since January 1, 2014. Mr. Chernow...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 19.8yrs | US$10.77m | 6.94% $ 341.0m | |
| Chief Executive Officer | 10.8yrs | US$10.71m | 0.73% $ 35.8m | |
| Executive VP & CFO | 1.1yrs | US$1.53m | 0.13% $ 6.5m | |
| Senior Executive VP | 27.8yrs | US$4.44m | 0.34% $ 16.6m | |
| Senior Executive Vice President of Strategic Finance & Operations | 1.1yrs | US$6.47m | 0.99% $ 48.5m | |
| Co-President | 1.1yrs | pas de données | 0.51% $ 25.1m | |
| Co-President | 1.1yrs | pas de données | 0.24% $ 12.0m | |
| Senior VP | 1.7yrs | pas de données | 0.027% $ 1.3m | |
| Executive VP & Chief Information Officer | 3.8yrs | pas de données | 0.23% $ 11.5m | |
| Senior Vice President of Compliance & Audit | no data | pas de données | 0.027% $ 1.3m | |
| Senior VP & Chief Communications | 1.1yrs | pas de données | pas de données | |
| Senior VP & Chief Human Resources Officer | 1.1yrs | pas de données | pas de données |
1.1yrs
Durée moyenne de l'emploi
55yo
Âge moyen
Gestion expérimentée: L'équipe de direction de SEM n'est pas considérée comme expérimentée (ancienneté moyenne 1.1 ans), ce qui suggère une nouvelle équipe.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 19.8yrs | US$10.77m | 6.94% $ 341.0m | |
| Independent Lead Director | 19.8yrs | US$384.40k | 0.85% $ 41.7m | |
| Independent Director | 20.8yrs | US$383.40k | 0.069% $ 3.4m | |
| Independent Director | 5.3yrs | US$405.80k | 0.051% $ 2.5m | |
| Independent Director | 14.5yrs | US$407.83k | 0.22% $ 10.9m | |
| Independent Director | 6yrs | US$394.40k | 0.042% $ 2.1m | |
| Independent Director | 16yrs | US$414.83k | 0.11% $ 5.6m | |
| Independent Director | 3.6yrs | US$409.80k | 0.036% $ 1.8m | |
| Independent Director | 3yrs | US$407.83k | 0.034% $ 1.7m |
14.5yrs
Durée moyenne de l'emploi
66yo
Âge moyen
Conseil d'administration expérimenté: Le conseil d'administration de la SEM est chevronné et expérimenté ( 14.5 années d'ancienneté moyenne).